Cargando…

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines

Substandard and falsified (SF) medicines are a global health challenge with the World Health Organization (WHO) estimating that 1 in 10 of medicines in low- and middle-income countries (LMICs) are SF. Antimicrobials (i.e. antimalarials, antibiotics) are the most commonly reported SF medicines. SF me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akpobolokemi, Tamara, Martinez-Nunez, Rocio Teresa, Raimi-Abraham, Bahijja Tolulope
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Special collection on the illicit trade of medicines online and falsified medicines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413333/ https://www.ncbi.nlm.nih.gov/pubmed/36204519 http://dx.doi.org/10.1177/23992026211070406

Ejemplares similares

A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives
por: Ahmed, Jamee, et al.
Publicado: (2022)

Evaluation of pharmacists’ awareness of illegal online pharmacies and perceived impact on safe access to medicines
por: Hertig, John B, et al.
Publicado: (2021)

Quality assessment of Diflucan(®) tablets distributed online: Diflucan(®) distributed online
por: Sanada, Tomoko, et al.
Publicado: (2021)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
por: McManus, Dominic, et al.
Publicado: (2020)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
por: Rojas-Cortés, Robin
Publicado: (2020)

pH Alteration in Plant-Mediated Green Synthesis and Its Resultant Impact on Antimicrobial Properties of Silver Nanoparticles (AgNPs)
por: Miranda, Amalia, et al.
Publicado: (2022)

Substandard and Falsified Medicines in Myanmar
por: Sakuda, Mirai, et al.
Publicado: (2020)

The economic impact of substandard and falsified antimalarial medications in Nigeria
por: Beargie, Sarah M., et al.
Publicado: (2019)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
por: Zabala, Guillermo A, et al.
Publicado: (2022)

Combatting Substandard and Falsified Medicines: A View from Rwanda
por: Binagwaho, Agnes, et al.
Publicado: (2013)

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
por: Ferrario, Alessandra, et al.
Publicado: (2019)

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
por: Jackson, Kathryn D., et al.
Publicado: (2020)

Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries
por: Kovacs, Stephanie, et al.
Publicado: (2014)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
por: Tabernero, Patricia, et al.
Publicado: (2022)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
por: Sweileh, Waleed M.
Publicado: (2021)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
por: El-Dahiyat, Faris, et al.
Publicado: (2021)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
por: Pisani, Elizabeth, et al.
Publicado: (2021)

Mobile apps for detecting falsified and substandard drugs: A systematic review
por: Ciapponi, Agustín, et al.
Publicado: (2021)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
por: Wada, Yusuf Hassan, et al.
Publicado: (2022)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
por: Cavany, Sean, et al.
Publicado: (2023)

Substandard and falsified medical product recalls in Zambia from 2018 to 2021 and implications on the quality surveillance systems
por: Chabalenge, Billy, et al.
Publicado: (2022)

Evaluating Low-Cost Optical Spectrometers for the Detection of Simulated Substandard and Falsified Medicines
por: Wang, Wenbo, et al.
Publicado: (2019)

Falsified and substandard cardiovascular drugs in Africa: a need for continued monitoring strategies
por: Antignac, Marie, et al.
Publicado: (2019)

The scourge of substandard and falsified medical products gets worse with COVID-19 pandemic
por: Shiferie, Fisseha, et al.
Publicado: (2020)

Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador
por: Yakhkind, Aleksandra, et al.
Publicado: (2022)

Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
por: Almuzaini, Tariq, et al.
Publicado: (2013)

Blockchain Technology for Detecting Falsified and Substandard Drugs in Distribution: Pharmaceutical Supply Chain Intervention
por: Sylim, Patrick, et al.
Publicado: (2018)

Retracted and Republished: A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
por: Tabernero, Patricia, et al.
Publicado: (2019)

Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries
por: Hauk, Cathrin, et al.
Publicado: (2021)

Usefulness of combined screening methods for rapid detection of falsified and/or substandard medicines in the absence of a confirmatory method
por: Opuni, Kwabena Frimpong-Manso, et al.
Publicado: (2019)

Social brains on drugs: tools for neuromodulation in social neuroscience
por: Crockett, Molly J., et al.
Publicado: (2014)

Hemorrhoidopexy with the HemorPex System
por: Tagliabue, M., et al.
Publicado: (2015)

Mesenteric tissue for the treatment of septic pelvic complications in the absence of greater omentum
por: de Groof, E. J., et al.
Publicado: (2016)

The “Cone” stoma: stoma creation in the presence of significant bowel dilatation
por: lo Conte, A., et al.
Publicado: (2019)

Gluteal transposition flap without donor site scar for closing a perineal defect after abdominoperineal resection
por: Blok, R. D., et al.
Publicado: (2016)

Some Criticisms Worthy of Attention
Publicado: (1920)

Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea
por: Kaur, Harparkash, et al.
Publicado: (2017)

Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries
por: Rasheed, Huma, et al.
Publicado: (2018)

The Epidemic of Substandard and Falsified Medications in Iraq: Evaluating the Effectiveness of National Pharmacovigilance Alerts to Community Pharmacies
por: Al-Jumaili, Ali Azeez, et al.
Publicado: (2021)

Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches
por: Ozawa, Sachiko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lmmqob837monjng2fcefj6l5hk